StonvexLoading…
StonvexStonvexStonvexCore line items from TDY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-28 | Annual 2024 2024-12-29 | Annual 2023 2023-12-31 | Annual 2023 2023-01-01 |
|---|---|---|---|---|
Revenue | $6.12B | $5.67B | $5.64B | $5.46B |
Operating Income | $1.15B | $989.10M | $1.03B | $972.00M |
Net Income | $894.80M | $819.20M | $885.70M | $788.60M |
EPS (Diluted) | $18.88 | $17.21 | $18.49 | $16.53 |
Total Assets | $15.29B | $14.20B | $14.53B | $14.35B |
Total Liabilities | $4.77B | $4.65B | $5.30B | $6.18B |
Cash & Equivalents | $352.40M | $649.80M | $648.30M | $638.10M |
Free Cash Flow OCF − CapEx | $1.07B | $1.11B | $721.20M | $394.20M |
Shares Outstanding | 46.19M | 46.71M | 47.33M | 46.91M |